| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Chief Financial Officer
3 companies
Richard A Meier is Director at BMRN and has filed Form 4s across 3 companies. Richard A Meier's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $7.6M at current prices.
The biggest single holding is BMRN (~$7.1M) as Director. The BMRN filings lean toward selling, a net 13,946 shares.
Richard A Meier has 27 Form 4 filings on record from July 2015 to October 2026, across 4 companies: Director at Accuray (ARAY), 2026; Director at Biomarin Pharmaceutical (BMRN), 2016–2025; EVP, Chief Financial Officer at Accendra Health (ACH), 2017–2018, and 1 more.
The 42 reported transactions were 13 stock awards, 10 option exercises, 8 open-market sales and 5 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 5 sales worth about $1.3M.
The largest open-market sale was 5,068 shares of BMRN at an average $78.38 on May 6, 2021, about $397K. Twelve months later BMRN was up 1%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2022 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE | 3,878 | $82.09 | $318,345.47 | -3.6% | +2.5% | +12.6% | |
| May 6, 2021 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE | 5,068 | $78.38 | $397,245.04 | -5.1% | -2.8% | +0.8% | |
| Sep 13, 2018 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE | 3,000 | $99.24 | $297,722.00 | -3.5% | - | - | |
| Aug 27, 2018 | BMRN Biomarin Pharmaceutical Inc | Director | Sale+OE | 2,000 | $100.12 | $200,235.40 | -2.8% | - | - | |
| May 20, 2016 | STAA Staar Surgical Co | Director | Sell | 25,000 | $5.35 | $133,849.33 | -57.7% | - | - |